Autolus Therapeutics plc American Depositary Share (NASDAQ: AUTL)
$2.2700
+0.0600 ( -1.30% ) 565.2K
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Market Data
Open
$2.2700
Previous close
$2.2100
Volume
565.2K
Market cap
$606.76M
Day range
$2.2020 - $2.3800
52 week range
$2.0700 - $7.3700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 153 | Nov 12, 2024 |
| 8-k | 8K-related | 35 | Nov 12, 2024 |
| 8-k | 8K-related | 38 | Nov 12, 2024 |
| 8-k | 8K-related | 54 | Sep 26, 2024 |
| 8-k | 8K-related | 18 | Sep 19, 2024 |
| 8-k | 8K-related | 14 | Sep 13, 2024 |
| 10-q | Quarterly Reports | 80 | Aug 08, 2024 |
| 8-k | 8K-related | 46 | Aug 08, 2024 |
| 8-k | 8K-related | 14 | Jun 28, 2024 |
| 8-k | 8K-related | 153 | Jun 05, 2024 |